Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer.
Humphries MP, Sundara Rajan S, Droop A, Suleman CAB, Carbone C, Nilsson C, Honarpisheh H, Cserni G, Dent J, Fulford L, Jordan LB, Jones JL, Kanthan R, Litwiniuk M, Di Benedetto A, Mottolese M, Provenzano E, Shousha S, Stephens M, Walker RA, Kulka J, Ellis IO, Jeffery M, Thygesen HH, Cappelletti V, Daidone MG, Hedenfalk IA, Fjällskog ML, Melisi D, Stead LF, Shaaban AM, Speirs V. Humphries MP, et al. Among authors: mottolese m. Clin Cancer Res. 2017 May 15;23(10):2575-2583. doi: 10.1158/1078-0432.CCR-16-1952. Epub 2016 Dec 16. Clin Cancer Res. 2017. PMID: 27986751 Free article.
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences.
Shaaban AM, Ball GR, Brannan RA, Cserni G, Di Benedetto A, Dent J, Fulford L, Honarpisheh H, Jordan L, Jones JL, Kanthan R, Maraqa L, Litwiniuk M, Mottolese M, Pollock S, Provenzano E, Quinlan PR, Reall G, Shousha S, Stephens M, Verghese ET, Walker RA, Hanby AM, Speirs V. Shaaban AM, et al. Among authors: mottolese m. Breast Cancer Res Treat. 2012 Jun;133(3):949-58. doi: 10.1007/s10549-011-1856-9. Epub 2011 Nov 18. Breast Cancer Res Treat. 2012. PMID: 22094935
Characterisation of male breast cancer: a descriptive biomarker study from a large patient series.
Humphries MP, Sundara Rajan S, Honarpisheh H, Cserni G, Dent J, Fulford L, Jordan LB, Jones JL, Kanthan R, Litwiniuk M, Di Benedetto A, Mottolese M, Provenzano E, Shousha S, Stephens M, Kulka J, Ellis IO, Titloye AN, Hanby AM, Shaaban AM, Speirs V. Humphries MP, et al. Among authors: mottolese m. Sci Rep. 2017 Mar 28;7:45293. doi: 10.1038/srep45293. Sci Rep. 2017. PMID: 28350011 Free PMC article.
Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.
Coulson-Gilmer C, Humphries MP, Sundara Rajan S, Droop A, Jackson S, Condon A, Cserni G, Jordan LB, Jones LJ, Kanthan R, Di Benedetto A, Mottolese M, Provenzano E, Kulka J, Shaaban AM, Hanby AM, Speirs V. Coulson-Gilmer C, et al. Among authors: mottolese m. J Pathol Clin Res. 2018 Oct;4(4):241-249. doi: 10.1002/cjp2.106. Epub 2018 Aug 23. J Pathol Clin Res. 2018. PMID: 29956502 Free PMC article.
HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient care.
Fabi A, Di Benedetto A, Metro G, Perracchio L, Nisticò C, Di Filippo F, Ercolani C, Ferretti G, Melucci E, Buglioni S, Sperduti I, Papaldo P, Cognetti F, Mottolese M. Fabi A, et al. Among authors: mottolese m. Clin Cancer Res. 2011 Apr 1;17(7):2055-64. doi: 10.1158/1078-0432.CCR-10-1920. Epub 2011 Feb 9. Clin Cancer Res. 2011. PMID: 21307144
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
Di Lauro L, Vici P, Barba M, Pizzuti L, Sergi D, Rinaldi M, Di Benedetto A, Sperduti I, Shaaban AM, Speirs V, Mottolese M, De Maria R, Maugeri-Saccà M. Di Lauro L, et al. Among authors: mottolese m. Breast Cancer Res Treat. 2014 Nov;148(1):73-80. doi: 10.1007/s10549-014-3138-9. Epub 2014 Sep 20. Breast Cancer Res Treat. 2014. PMID: 25238881
Androgen receptor and antiandrogen therapy in male breast cancer.
Di Lauro L, Barba M, Pizzuti L, Vici P, Sergi D, Di Benedetto A, Mottolese M, Speirs V, Santini D, De Maria R, Maugeri-Saccà M. Di Lauro L, et al. Among authors: mottolese m. Cancer Lett. 2015 Nov 1;368(1):20-25. doi: 10.1016/j.canlet.2015.07.040. Epub 2015 Aug 11. Cancer Lett. 2015. PMID: 26276719 Free article. Review.
The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.
Di Benedetto A, Mottolese M, Sperati F, Ercolani C, Di Lauro L, Pizzuti L, Vici P, Terrenato I, Sperduti I, Shaaban AM, Sundara-Rajan S, Barba M, Speirs V, De Maria R, Maugeri-Saccà M. Di Benedetto A, et al. Among authors: mottolese m. Oncotarget. 2016 Jul 12;7(28):43188-43198. doi: 10.18632/oncotarget.9668. Oncotarget. 2016. PMID: 27248471 Free PMC article.
HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.
Di Benedetto A, Mottolese M, Sperati F, Ercolani C, Di Lauro L, Pizzuti L, Vici P, Terrenato I, Shaaban AM, Sundara-Rajan S, Humphries MP, Barba M, Speirs V, De Maria R, Maugeri-Saccà M. Di Benedetto A, et al. Among authors: mottolese m. Sci Rep. 2016 Oct 7;6:35121. doi: 10.1038/srep35121. Sci Rep. 2016. PMID: 27713571 Free PMC article.
Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.
Di Benedetto A, Mottolese M, Sperati F, Ercolani C, Di Lauro L, Pizzuti L, Vici P, Terrenato I, Shaaban AM, Humphries MP, Sundara-Rajan S, Barba M, Speirs V, De Maria R, Maugeri-Saccà M. Di Benedetto A, et al. Among authors: mottolese m. J Cell Physiol. 2017 Aug;232(8):2246-2252. doi: 10.1002/jcp.25745. Epub 2017 Mar 3. J Cell Physiol. 2017. PMID: 27987320 Free article.
243 results